Opportunities for Pilot Projects from Cancer Innovation Award

DEADLINE:  Friday, August 3, 2018

The Case Comprehensive Cancer Center is providing seed funding for highly innovative and impactful proposals that will generate key data for larger, nationally competitive grants. Projects must be transformative in nature and may focus on technology development, innovative biological or therapeutic questions, novel concepts in catchment-based research, or topics that have the potential to overturn dogma. Investigators should submit novel ideas which may be high risk but are exceptionally innovative.

This RFA is open to all Case Comprehensive Cancer Center Members. These projects must not be currently funded by other sources or by the Cancer Center.

AWARD DESCRIPTION

  • Up to 5 research projects will be funded. Total funds committed to this RFA are $250,000.
  • Each research project can request a budget of up to $50,000 for one year.
  • Research projects should be completed within one year.

FUNDING CRITERIA

  • Strong investigative teams of Case Comprehensive Cancer Center members.
  • New and highly innovative concepts that have the potential to be transformative.
  • Projects cannot be currently funded from any source.
  • All materials to complete the project should be in-hand or readily available. For example, tissue-based research that requires an approved IRB protocol and patient cohort studies must have already recruited the cohort. Collection of new patient cohorts as the primary focus of the work is not responsive to this RFA.
  • While investigators can be collaborators on multiple applications, only one application will be accepted per lead PI.
  • All funds for shared resources must use Case Comprehensive Cancer Center shared resources, when available, rather than shared resources at institutions outside Cleveland unless a specific justification for use of another shared resources is submitted and approved.

FORMS

View Instructions
View Cover Sheet

CONTACT

Contact casecccpilots@case.edu or John Pounardjian at 216.368.0846 with any questions.